Parkinson's Disease/Movement Disorders News

CHICAGO — While there is significant interest in the Black community to learn about Parkinson’s disease research and study participation, interventions are needed to reduce recruitment barriers and improve access to information.

CHICAGO — Active electrode placement in the right subthalamic nucleus in deep brain stimulation was associated with weight gain in patients with Parkinson’s disease, with lesser gain reported with medially placed electrodes.

CHICAGO — Quetiapine remains the drug of choice for psychosis in patients with Parkinson’s disease dementia and dementia with Lewy bodies, per data at the International Association of Parkinsonism and Related Disorders World Congress.

CHICAGO — Patients with tardive dyskinesia reported greater impact on quality of life than health care providers, according to a poster at the International Association of Parkinsonism and Related Disorders World Congress.

CHICAGO — Tributyrin supplementation may have a beneficial effect on motor symptoms and inflammatory markers in Parkinson’s disease, according to data at the International Association of Parkinsonism and Related Disorders World Congress.

CHICAGO — Continuous subcutaneous apomorphine infusion reduced “off” time and increased “on” time without troublesome dyskinesia in patients with Parkinson’s disease in the United States, with no new safety signals reported.

CHICAGO — Researchers have reported a link between a novel DCTN1 variant and Perry syndrome, which was identified both in asymptomatic individuals and those with mild neurological abnormalities, suggesting a prodromal stage of disease.

CHICAGO – The Huntington Disease Health Index was an accurate, clinically meaningful tool for participants in the KINECT-HD trial to report symptomatic disease burden changes when treated with valbenazine, according to a recent study.

CHICAGO — The International Association of Parkinsonism and Related Disorders has honored three young investigators for their outstanding research related to Parkinson’s disease.

A patient’s duration of Parkinson’s disease can affect visual field sensitivity, according to a poster presented at the North American Neuro-Ophthalmology Society meeting.